Cita APA (7a ed.)
K, B., M, S., SP, C., B, T., & C, W. (2010). Influence of CYP2C19 genotype on the pharmacokinetics of R483, a CYP2C19 substrate, in healthy subjects and type 2 diabetes patients. European Journal of Clinical Pharmacology, 66(10), 1005-1016.
Cita Chicago Style (17a ed.)
K, Bogman, Silkey M, Chan SP, Tomlinson B, y Weber C. "Influence of CYP2C19 Genotype on the Pharmacokinetics of R483, a CYP2C19 Substrate, in Healthy Subjects and Type 2 Diabetes Patients." European Journal of Clinical Pharmacology 66, no. 10 (2010): 1005-1016.
Cita MLA (9a ed.)
K, Bogman, et al. "Influence of CYP2C19 Genotype on the Pharmacokinetics of R483, a CYP2C19 Substrate, in Healthy Subjects and Type 2 Diabetes Patients." European Journal of Clinical Pharmacology, vol. 66, no. 10, 2010, pp. 1005-1016.
Precaución: Estas citas no son 100% exactas.